Petra Cetkovská

770 total citations
32 papers, 345 citations indexed

About

Petra Cetkovská is a scholar working on Dermatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Petra Cetkovská has authored 32 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Dermatology, 12 papers in Immunology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Petra Cetkovská's work include Dermatology and Skin Diseases (12 papers), Psoriasis: Treatment and Pathogenesis (12 papers) and Autoimmune Bullous Skin Diseases (7 papers). Petra Cetkovská is often cited by papers focused on Dermatology and Skin Diseases (12 papers), Psoriasis: Treatment and Pathogenesis (12 papers) and Autoimmune Bullous Skin Diseases (7 papers). Petra Cetkovská collaborates with scholars based in Czechia, United States and Netherlands. Petra Cetkovská's co-authors include Karel Pizinger, Petr Cetkovský, Spyridon Gkalpakiotis, Martina Kojanová, Tomáš Doležal, Petr Arenberger, Nico P.M. Smit, H. van der Meulen, Coby Out and Frans van Nieuwpoort and has published in prestigious journals such as Journal of the American Academy of Dermatology, European Journal of Cancer and British Journal of Dermatology.

In The Last Decade

Petra Cetkovská

31 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petra Cetkovská Czechia 10 174 132 75 59 47 32 345
Mark BY Tang Singapore 13 211 1.2× 81 0.6× 100 1.3× 97 1.6× 62 1.3× 21 422
Maria Laura Flori Italy 12 225 1.3× 68 0.5× 29 0.4× 39 0.7× 48 1.0× 24 347
Mona R. E. Abdel‐Halim Egypt 12 214 1.2× 124 0.9× 22 0.3× 83 1.4× 70 1.5× 50 372
Gülcan Saylam Kurtipek Türkiye 9 92 0.5× 107 0.8× 97 1.3× 49 0.8× 25 0.5× 41 289
Shunli Tang China 11 147 0.8× 215 1.6× 98 1.3× 87 1.5× 118 2.5× 24 496
Gianluca Pagnanelli Italy 9 165 0.9× 236 1.8× 42 0.6× 44 0.7× 40 0.9× 21 337
Karl M. Hoegler United States 6 103 0.6× 115 0.9× 27 0.4× 44 0.7× 35 0.7× 15 244
Julianty Angsana United States 8 79 0.5× 187 1.4× 34 0.5× 15 0.3× 17 0.4× 11 314
S. Majewski United States 10 86 0.5× 56 0.4× 36 0.5× 76 1.3× 52 1.1× 22 319
Fumiko Suenaga Japan 7 85 0.5× 210 1.6× 42 0.6× 24 0.4× 70 1.5× 8 477

Countries citing papers authored by Petra Cetkovská

Since Specialization
Citations

This map shows the geographic impact of Petra Cetkovská's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Cetkovská with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Cetkovská more than expected).

Fields of papers citing papers by Petra Cetkovská

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Cetkovská. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Cetkovská. The network helps show where Petra Cetkovská may publish in the future.

Co-authorship network of co-authors of Petra Cetkovská

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Cetkovská. A scholar is included among the top collaborators of Petra Cetkovská based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Cetkovská. Petra Cetkovská is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cetkovská, Petra, et al.. (2023). Apremilast Use in Severe Psoriasis: Real-World Data from Central and Eastern Europe. Advances in Therapy. 40(4). 1787–1802. 6 indexed citations
3.
Gkalpakiotis, Spyridon, Martina Kojanová, Petra Cetkovská, et al.. (2023). Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic. Dermatology and Therapy. 14(1). 115–130. 1 indexed citations
4.
5.
Gkalpakiotis, Spyridon, Petra Cetkovská, Petr Arenberger, et al.. (2021). Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic. Dermatology and Therapy. 11(4). 1345–1355. 29 indexed citations
6.
Kojanová, Martina, et al.. (2021). Real-World Evidence From More Than 1000 Patients Treated With Adalimumab For Moderate-to-Severe Psoriasis in the Czech Republic. Dermatology and Therapy. 11(2). 543–553. 12 indexed citations
7.
8.
Cetkovská, Petra, et al.. (2020). Successful treatment of refractory extensive pityriasis rubra pilaris with risankizumab. British Journal of Dermatology. 184(5). e148–e148. 7 indexed citations
9.
Panzner, Petr, et al.. (2020). Use of dupilumab in a patient with atopic dermatitis, severe asthma, and HIV infection. Dermatologic Therapy. 33(6). e14159–e14159. 9 indexed citations
10.
Čelakovská, Jarmila, Josef Bukač, Jaroslava Vaněčková, et al.. (2020). Food hypersensitivity reactions to seafish in atopic dermatitis patients older than 14 year of age – The evaluation of association with other allergic diseases and parameters. Indian Journal of Dermatology. 65(2). 97–97. 5 indexed citations
11.
Kemény, Lajos, Petra Cetkovská, Natta Rajatanavin, et al.. (2015). Effect of etanercept therapy on psoriasis symptoms in patients from Latin America, Central Europe, and Asia: a subset analysis of the PRISTINE trial. BMC Dermatology. 15(1). 9–9. 6 indexed citations
12.
Cetkovská, Petra, et al.. (2014). Management of a pemphigus with IgA and IgG antibodies and coexistent lung cancer. Dermatologic Therapy. 27(4). 236–239. 5 indexed citations
13.
Kemény, Lajos, Petra Cetkovská, Laura Galimberti, et al.. (2013). Etanercept Provides Improved Quality of Life Regardless of the Presence of Psoriatric Arthritis in Moderate/Severe Psoriasis Subjects from Central and Eastern Europe, Latin America and Asia. Value in Health. 16(7). A509–A509. 2 indexed citations
14.
Kacerovská, Denisa, et al.. (2007). Genital Warts Treated By Photodynamic Therapy. SKINmed Dermatology for the Clinician. 6(6). 295–297. 24 indexed citations
15.
Cetkovská, Petra & Karel Pizinger. (2006). Coexisting subacute and systemic lupus erythematosus after terbinafine administration: successful treatment with mycophenolate mofetil. International Journal of Dermatology. 45(3). 320–322. 22 indexed citations
16.
Pavel, Stan, Frans van Nieuwpoort, H. van der Meulen, et al.. (2004). Disturbed melanin synthesis and chronic oxidative stress in dysplastic naevi. European Journal of Cancer. 40(9). 1423–1430. 66 indexed citations
17.
Cetkovská, Petra, Karel Pizinger, & Alena Skálová. (2003). Epidermolysis bullosa acquisita–like reaction associated with penicillamine therapy for sclerodermatous graft-versus-host disease. Journal of the American Academy of Dermatology. 49(6). 1157–1159. 3 indexed citations
18.
Cetkovská, Petra, Karel Pizinger, & Petr Cetkovský. (2002). High‐dose cytosine arabinoside‐induced cutaneous reactions. Journal of the European Academy of Dermatology and Venereology. 16(5). 481–485. 30 indexed citations
19.
Cetkovský, Petr, et al.. (1998). Successful treatment of severe Shulman’s syndrome by allogeneic bone marrow transplantation. Bone Marrow Transplantation. 21(6). 637–639. 23 indexed citations
20.
Cetkovská, Petra, et al.. (1997). FC150 Cutaneous toxicity associated with high-dose cytosine arabinoside. Journal of the European Academy of Dermatology and Venereology. 9. S151–S151. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark BY Tang Breakdown of academic impact, for papers by Maria Laura Flori Breakdown of academic impact, for papers by Mona R. E. Abdel‐Halim Breakdown of academic impact, for papers by Gülcan Saylam Kurtipek Breakdown of academic impact, for papers by Shunli Tang Breakdown of academic impact, for papers by Gianluca Pagnanelli Breakdown of academic impact, for papers by Karl M. Hoegler Breakdown of academic impact, for papers by Julianty Angsana Breakdown of academic impact, for papers by S. Majewski Breakdown of academic impact, for papers by Fumiko Suenaga
Rankless by CCL
2026